español

16
Apr

STUDIES CHECK A NEW THERAPEUTIC ALTERNATIVE FOR CHILDHOOD NEUROLOGICAL DISORDERS

It is the non-invasive method of hyperbaric oxygenation. It is indicated for autism, cerebral palsy and headaches, among other pathologies. In the long term, it offers obvious benefits in the improvement of motor function. Childhood neurological disorders are diseases of the central and peripheral nervous system that affect the brain, spinal cord, nerves and muscles of the child. They can

Read more

10
Apr

BioBarica will participate in the ARTHROMEETING

BioBarica will be present at the ARTHROMEETING in Rozzano, Milano. The event will be held at the Humanitas Research Hospital, on April 13th, 2019, starting at 9:00 A.M. The objective of the day is to tackle the functional recovery in the athlete’s knee. The meeting will be under the presidency of doctors Enrico Arnaldi and Piero Volpi. The scientists responsible

Read more

27
Mar

BioBarica is at the XXXVI National FMSI Congress in Rome

BioBarica is at the XXXVI National FMSI Congress in Rome. The event takes place at the “Rome Cavalieri” Hilton Conference Center, from March 27th to 29th, 2019. The objective of the conference is to provide professional training and updating, but it is also a time of fruitful encounter and comparison between all members of the FMSI. This Congress has a

Read more

19
Mar

BioBarica publishes its first statistical cut of clinical cases

In its latest edition of 2018, the magazine of the Argentine Medical Association included the first statistical cut of the cases treated with the Revitalair 430 hyperbaric chambers. In “Medical applications of the new generation of hyperbaric oxygenation chambers”, BioBarica presents a review of all the new emergent applications of Hyperbaric Oxygen Therapy in several medical specialties, due to the

Read more

14
Mar

Dr Elías López: hyperbaric oxygen cures diabetic foot wounds in 60% of cases

Dr. Elías López, head of BioBarica at the Santa Elena Clinic (Madrid), has pointed out that, although the response to the treatment of each patient is different, hyperbaric oxygen therapy (HBOT) improves the symptoms of 90% of the patients affected by diabetic foot and completely heals wounds in 60 percent of cases, rising to 80 percent when treatment starts early

Read more

12
Mar

Sudden sensorineural hearing loss: role of hyperbaric oxygen therapy

Sudden sensorineural hearing loss (SSNHL) is defined as an acute hearing reduction, typically unilateral, of 30 dB or more in at least three consecutive frequencies, occurring within 72 hours of symptom onset. It was first described in 1926 as Citelli’s acute cochlear block and is currently more commonly referred to as idiopathic sudden sensorineural hearing loss (ISSNHL). There are approximately

Read more

26
Feb

Diabetic hand infections and hyperbaric oxygen therapy

According to the World Health Organization (WHO), 346 million people have diabetes worldwide and the number of diabetics is predicted to double between 2005 and 2030. Foot ulcers are one of the most important complications of diabetes and cause high rates of amputation. Diabetic hand infections are observed less frequently than foot infections. Hand infections related to diabetes have mostly

Read more

21
Feb

New center in Abu Dhabi

BioBarica opened a new center in Abu Dhabi. Ibrahim Shehata, the sales coordinator of the region, was present at the installation of the hyperbaric chamber and offered training to the staff that operates the unit. Hyperbaric chamber treatment is a non-invasive method that consists of supplying air and oxygen under pressure in a pressurized cabin at 1.4 atmospheres (ATM). The normal ambient atmospheric pressure is

Read more

21
Feb

The hyperbaric chamber: adjuvant of neurorehabilitation therapy

Stroke is the leading cause of disability in the world. It is estimated that of the 15 million people who have suffered one, 5 million have been left with permanent sequelae, such as motor, sensory disorders, urinary incontinence, speech alteration, and understanding, etc. “When a stroke occurs, the time to apply a treatment to return the blood supply and the

Read more

14
Feb

Use of hyperbaric oxygen in rheumatic diseases: case report and critical analysis

Hyperbaric oxygen has been used in patients with rheumatic disease for many years without reports of untoward or unusual complications for a variety of non-rheumatic indications. Recent evidence that hyperbaric oxygen inhibits the actions of certain cytokines, acts as an immune modulator and may help cognitive dysfunction has resulted in a re-examination of its potential role in rheumatic diseases. This

Read more